Can Mounjaro Give You Chills?

What Mounjaro's licensed prescribing data actually records

The Summary of Product Characteristics for tirzepatide, published on the electronic Medicines Compendium, lists the most commonly observed side effects as gastrointestinal: nausea, diarrhoea, vomiting, constipation, and indigestion. Fatigue and dizziness appear too. Chills as a standalone symptom are not in that list. That matters, because the SmPC is built from data across the SURMOUNT clinical programme, which randomised thousands of adults over trials lasting up to 72 weeks — it is the most reliable record of what the medicine itself causes at population level.

The NHS's medicines information for tirzepatide echoes this picture. Neither source calls chills a known direct effect. That said, absence from the SmPC does not mean absence in real life. Post-marketing experience, Yellow Card reports, and the lived accounts of people on treatment regularly surface symptoms that did not reach statistical significance in controlled trials. The honest answer is that chills are not a recognised direct pharmacological effect of tirzepatide, but the reasons people on Mounjaro sometimes feel shivery are worth understanding properly.

If you want to check the full side-effect profile yourself, the NHS's medicines page for tirzepatide is a clear, patient-level resource that takes under a minute to read through.

The more likely explanations behind that shivery feeling

Mounjaro works by activating both GIP and GLP-1 receptors, which curbs appetite significantly and slows the rate at which the stomach empties. In practice this means people eat considerably less, sometimes very quickly. A meaningful drop in calorie intake reduces the energy available for thermogenesis — the process by which your body generates heat. People often notice they feel colder in general as their weight falls, and this can begin well before dramatic weight loss is visible, simply because the metabolic slowdown from eating less takes effect almost immediately.

There is a second, more acute route to that chilly feeling. Nausea (one of the genuinely common side effects) can trigger sweating. Once the nausea eases and the sweat cools on the skin, the result is exactly the clammy, shivery sensation people describe as chills. This pattern tends to be most noticeable in the first four to eight weeks, and especially in the 24 to 48 hours after each injection, when tirzepatide concentrations are rising. If you are newer to treatment and want to make sure you are injecting correctly, our guide on how to give Mounjaro walks through the technique step by step, which can help rule out any administration issues contributing to how you feel. For many people it settles as the body adjusts, and it often improves further at each new dose level after the initial adjustment period passes.

Dehydration is a third factor worth considering. Persistent nausea, vomiting, or diarrhoea can deplete fluid levels enough to affect circulation and temperature regulation. Keeping up fluid intake on days when GI symptoms are active is a straightforward habit that can reduce how rough those early weeks feel. You can read more about the full range of gastrointestinal effects in our overview of Mounjaro and digestive side effects.

When chills alongside other symptoms need prompt attention

Context matters enormously with this symptom. A mild, passing chill in the day or two after an injection, with no other symptoms, is unlikely to signal anything serious. Chills that arrive alongside severe, persistent abdominal pain (particularly pain that radiates towards the back) are a different matter. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the regulator's guidance is to seek urgent medical help for severe or persistent stomach pain in this context, with or without vomiting.

Rigors (pronounced shaking chills) or chills accompanied by fever, a rapid heart rate, or pain elsewhere may point to an infection or another condition unrelated to Mounjaro. These warrant a call to your GP or, if severe, NHS 111. It is also worth knowing that injection-site reactions occasionally cause a localised flushing or warmth followed by a cool sensation, though this is usually brief and contained to the injection area. Our dedicated page on chills and Mounjaro covers additional practical detail on how to tell a minor reaction from one that needs follow-up.

One practical habit: after your injection each week, note the time and jot down any symptoms, just a quick note on your phone. If chills or other effects consistently appear at a particular point after dosing, that pattern is useful information for your prescriber when you next speak. If you are also wondering whether your treatment affects other health activities, our page on whether you can give blood on Mounjaro is worth a read before your next donation appointment.

How a clinical review connects these dots for your situation

Tirzepatide is a prescription-only medicine, and the right person to interpret any symptom in the context of your health history is a clinician. That is why every repeat order at nume goes back through a prescriber before it is dispensed, a real clinician looks at your answers, not an automated queue. If chills have been bothering you, that conversation is exactly what the review process is designed for.

If you are considering starting treatment and want to understand the full picture before you begin, our tirzepatide information page covers how the medicine works in detail, and our Mounjaro page sets out what to expect across the treatment journey. For a broader look at weight-loss options, our treatment overview compares what is currently licensed in the UK.

Suspected side effects (whether or not they are listed in the SmPC) can be reported directly to the MHRA through the Yellow Card scheme. Patient reports genuinely inform how post-marketing safety data develops, so it is always worth submitting one if something concerns you.

If you would like a clinician to review whether Mounjaro is suitable for you, start your free consultation and a GPhC-registered prescriber will assess your answers the same day.